A factor secreted by a human pulmonary alveolar epithelial-like cell line blocks T-cell proliferation between G1 and S phase.

Because the pulmonary alveolar space is both the site of gas exchange for respiration and a portal of entry for foreign antigen, immunologic interactions within that space must be meticulously controlled. Alveolar epithelial cells are ideally situated to play a role in immune regulation within the alveolar space. We have used A549 cells, a cell line that is derived from a human alveolar cell carcinoma and that has been used as a model for alveolar type II epithelial cells, to examine the potential role of alveolar epithelial cells in local pulmonary immune regulation. Medium conditioned by confluent monolayers of A549 cells suppressed proliferation by human peripheral blood mononuclear cells (PBMC) stimulated with lectin, anti-CD3 antibodies, calcium ionophore and phorbol ester, or in a mixed leukocyte reaction. PBMC that had been incubated in and then removed from A549-conditioned medium went on to proliferate normally. Because the suppressive effect was abrogated by heating or acidification and was not blocked by neutralizing antibody to transforming growth factor-beta 1, this effect could not be attributed to transforming growth factor-beta. The factor mediating this effect has an approximate molecular weight of 70,000 D by gel filtration chromatography. Nonalveolar, pulmonary carcinoma cell lines did not exert this immunosuppressive influence nor did the alveolar epithelial cells inhibit proliferation by the transformed, Jurkat, T-cell line. Cell cycle analysis demonstrated that PBMC exposed to A549 cell-conditioned medium failed to enter S phase after mitogen stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  C. Mody,et al.  Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. , 1991, American journal of respiratory cell and molecular biology.

[2]  L. Mayer,et al.  Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. , 1991, American journal of respiratory cell and molecular biology.

[3]  C. Thompson,et al.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. , 1991, The Journal of clinical investigation.

[4]  Z. Toossi,et al.  Requirement for cell-to-cell contact for the immunosuppressive activity of human alveolar macrophages. , 1991, American journal of respiratory cell and molecular biology.

[5]  C. Thompson,et al.  Guanine ribonucleotide depletion inhibits T cell activation. , 1991, Advances in experimental medicine and biology.

[6]  T. Standiford,et al.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. , 1990, The Journal of clinical investigation.

[7]  M. Peters-Golden,et al.  Arachidonate metabolism increases as rat alveolar type II cells differentiate in vitro. , 1990, The American journal of physiology.

[8]  H. Weiner,et al.  Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cells. , 1990, Cellular immunology.

[9]  C. Thompson,et al.  CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. , 1990, Journal of immunology.

[10]  J. Lacy,et al.  Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor. , 1990, American journal of respiratory cell and molecular biology.

[11]  J. Siegfried Culture of primary lung tumors using medium conditioned by a lung carcinoma cell line , 1989, Journal of cellular biochemistry.

[12]  G. Crabtree Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.

[13]  M. Jenkins,et al.  Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. , 1988, Journal of immunology.

[14]  R. Crystal,et al.  T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. , 1988, Clinical immunology and immunopathology.

[15]  Ralb The normal lung. , 1987 .

[16]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[17]  K. Nishioka,et al.  Ia antigen expressed by keratinocytes can be the molecule of antigen presentation in contact sensitivity. , 1987, The Journal of investigative dermatology.

[18]  M. Sporn,et al.  Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.

[19]  R. Crystal,et al.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset. , 1986, The Journal of clinical investigation.

[20]  P. Bland,et al.  Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. , 1986, Immunology.

[21]  P. Bland,et al.  Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells. , 1986, Immunology.

[22]  M. Sporn,et al.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth , 1986, The Journal of experimental medicine.

[23]  P. Golstein,et al.  Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester , 1985, Nature.

[24]  R. G. Sitrin,et al.  The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro. , 1985, Experimental lung research.

[25]  J. Uhr,et al.  Antigen presentation by guinea pig alveolar macrophages. , 1981, Journal of immunology.

[26]  B. Benson,et al.  Identification of the immunosuppressive components of canine pulmonary surface active material. , 1980, Journal of immunology.

[27]  P. Holt Alveolar macrophages. IV. Interspecies differences in activity in proliferating lymphocyte cultures. , 1980, Cellular immunology.

[28]  M. Williams,et al.  Phospholipid composition and ultrastructure of A549 cells and other cultured pulmonary epithelial cells of presumed type II cell origin. , 1980, Biochimica et biophysica acta.

[29]  V. Ferrans,et al.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.

[30]  B. Benson,et al.  Immunosuppressive activity of canine pulmonary surface active material. , 1979, Journal of immunology.

[31]  B. Smith Cell line A549: a model system for the study of alveolar type II cell function. , 1977, The American review of respiratory disease.

[32]  J. Bienenstock,et al.  Lung defense mechanisms (second of two parts). , 1976, The New England journal of medicine.

[33]  J. Bienenstock,et al.  Lung defense mechanisms (first of two parts). , 1976, The New England journal of medicine.

[34]  Barry H. Smith,et al.  A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.

[35]  M. Altose,et al.  Immunocompetent cells from the lower respiratory tract of normal human lungs. , 1975, The Journal of clinical investigation.